Cargando…

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study

Detalles Bibliográficos
Autor principal:	Sedaghat, Nahad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164730/ https://www.ncbi.nlm.nih.gov/pubmed/34102605 http://dx.doi.org/10.1016/j.msard.2021.103054

Ejemplares similares

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
por: Barzegar, Mahdi, et al.
Publicado: (2021)

Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
por: Sedaghat, Nahad, et al.
Publicado: (2022)

Commentary: Coronavirus disease 2019 (COVID-19) and the airway: How can surgery help?
por: Rendina, Erino Angelo, et al.
Publicado: (2020)

The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect?
por: Maoujoud, Omar, et al.
Publicado: (2020)

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Successful seroconversion following mild COVID-19 contraction in a double-vaccinated B-cell-depleted person with multiple sclerosis: A hint towards booster efficacy?
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Multiple sclerosis in sarcoidosis patients: Two case reports
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Myasthenia gravis and coronavirus disease 2019: A report from Iran
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation
por: Steelman, Andrew J.
Publicado: (2015)

Commentary: Training in the time of coronavirus disease 2019 (COVID-19)
por: Tibayan, Frederick A.
Publicado: (2021)

Commentary: Obesity in the time of coronavirus disease 2019 (COVID-19)
por: Shah, Ashish S.
Publicado: (2021)

Commentary: Can we do better during a potential second wave of coronavirus disease 2019 (COVID-19)?
por: Engelman, Daniel T., et al.
Publicado: (2020)

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Some ethical concerns related to the coronavirus disease 2019 (COVID-19)
por: Montazeri, Ali
Publicado: (2020)

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals
por: Mahoney, Monica V., et al.
Publicado: (2022)

Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion
por: Yamoah, Peter, et al.
Publicado: (2020)

Commentary: Coronavirus disease 2019 (COVID-19) tracheostomies—The “how” but not the “why” or “when”
por: Wei, Benjamin, et al.
Publicado: (2021)

Commentary: Zoom into the coronary anastomosis during coronavirus disease 2019 (COVID-19)
por: Ahmad, Danial, et al.
Publicado: (2021)

Commentary: The importance of operative timing in the era of coronavirus disease 2019 (COVID-19)
por: Costello, John P., et al.
Publicado: (2021)

Commentary: Coronavirus disease 2019 (COVID-19): The long (term) and short (term) of it
por: Wisniewski, Alex M., et al.
Publicado: (2021)

Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine
por: Etemadifar, Masoud, et al.
Publicado: (2023)

Commentary: Implications of coronavirus disease 2019 (COVID-19) for cardiac surgery: Priorities and decisions
por: Rajagopal, Keshava
Publicado: (2020)

Management of bacteriological specimens of patients suffering from coronavirus disease 2019 (COVID-19)
por: Hogardt, Michael, et al.
Publicado: (2021)

Commentary: Coronavirus disease 2019 (COVID-19): Art imitates life—save the population
por: Inra, Matthew L., et al.
Publicado: (2022)

Coronavirus disease 2019 (COVID-19) and physicians with a disability: a compounding stressor
por: Ayyala, Rama S.
Publicado: (2022)

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Commentary: Vulnerability and resilience demonstrated: Cardiac surgeons during coronavirus disease 2019 (COVID-19)
por: Silvestry, Scott C.
Publicado: (2020)

Commentary: Adapting the practice of congenital heart surgery to the coronavirus disease 2019 (COVID-19) pandemic
por: Bacha, Emile
Publicado: (2021)

Commentary: Should surgeons challenge the unknown sequela of the coronavirus disease 2019 (COVID-19) virus?
por: Azevedo, Ivan, et al.
Publicado: (2020)

Commentary: Cardiothoracic surgery and coronavirus disease 2019 (COVID-19): A surge of collective strength
por: Han, Jason J., et al.
Publicado: (2020)

Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
por: Villani, Alessia, et al.
Publicado: (2020)

Commentary: What has the coronavirus disease 2019 (COVID-19) pandemic really taught us?
por: Wang, Hanghang, et al.
Publicado: (2021)

Proposal for Coronavirus Disease 2019 Management
por: Downs, John B., et al.
Publicado: (2020)

A real-time policy dashboard can aid global transparency in the response to coronavirus disease 2019
por: Head, Michael G
Publicado: (2020)

Commentary: Respiratory failure in patients with Coronavirus Disease 2019 infection: Can extracorporeal membrane oxygenation help?
por: Ferraris, Victor A.
Publicado: (2023)

Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity
por: Sedaghat, Nahad, et al.
Publicado: (2023)

Commentary: Performing cardiac surgery in the coronavirus disease 2019 (COVID-19) era: What is the new normal?
por: Mohammadi, Siamak, et al.
Publicado: (2020)

Commentary: Cardiac surgery and coronavirus disease 2019 (COVID-19): Lessons learned in Italy—the hard way
por: Duncan, Andra E.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_806e5t3b5laak4uhf38mrg2ike